Quinine disposition in globally malnourished children with cerebral malaria

Clinical Pharmacology and Therapeutics

Volumn 65, Issue 5, 1999, Pages 500-510

  Pussard, Eric ^a,b,c   Barennes, Hubert ^a,b,c   Daouda, Hamani ^a,b,c   Clavier, Françoise ^a,b,c   Sani, Abdoulaye Mahaman ^a,b,c   Osse, Martin ^a,b,c   Granic, Gérard ^a,b,c   Verdier, Françoise ^a,b,c  

^a Inst de Med et d'Epidemiol A   (France)

^b BICÊTRE HOSPITAL   (France)

^c Faculte des Sciences de la Sante   (Niger)

Author keywords

[No Author keywords available]

Indexed keywords

CINCHONIDINE; CINCHONINE; QUINIDINE; QUININE;

ARTICLE; BRAIN MALARIA; CHILD; CINCHONA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG CLEARANCE; DRUG DISPOSITION; DRUG EFFECT; HUMAN; MALNUTRITION; PRIORITY JOURNAL;

EID: 0032961539     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(99)70069-X     Document Type: Article

References (36)

1. 1. Krishna S, White NJ. Pharmacokinetics of quinine, chloroquine and amodiaquine: clinical implications. Clin Pharmacokinet 1996;30:263-99.
2. 2. Krishnaswamy K. Drug metabolism and pharmacokinetics in malnourished children. Clin Pharmacokinet 1989; 17:68-88.
3. 3. Salako LA, Sowumni A, Akinbami FO. Pharmacokinetics of quinine in African children suffering from kwashiorkor. Br J Clin Pharmacol 1989;28:197-201.
4. 4. Treluyer JM, Roux A, Mugnier C, Flouvat B, Lagardère B. Metabolism of quinine in children with global malnutrition. Pediatr Res 1996;40:558-63.
5. 5. Centers for Disease Control. Anthropometric software package. Developed by the Division of Nutrition, Center for Health Promotion and Education, Atlanta (GA); 1986.
6. 6. Waterlow JC. Protein-energy malnutrition. In: Arnold E, editor. 2nd ed. London; 1992.
7. 7. Gorstein J. Assessment of nutritional status: effects of different methods to determine age on the classification of undernutrition. Bull World Health Organ 1989;67:143-50.
8. 8. Molyneux ME, Taylor TE, Wirima JJ, Brogstein A. Clinical features and prognostic indicators in pediatric cerebral malaria: a study of 131 comatose Malawian Children. Q J Med 1989;71:441-59.
9. 9. Severe and complicated malaria. World Health Organization, Division of Control of Tropical Diseases. Trans R Soc Trop Med Hyg 1990;84(suppl 2): 1-65.
10. 10. Winstanley PA, Mberu EK, Watkins WM, Murphy SA, Lowe B, Marsh K. Towards optimal regimens of parenteral quinine for young African children with cerebral malaria: unbound quinine concentrations following a simple loading dose regimen. Trans R Soc Trop Med Hyg 1994;88:577-80.
11. 11. Barennes H, Pussard E, Mahaman Sani A, Clavier F, Kahiatani F, Granic G, et al. Efficacy and pharmacokinetics of a new intrarectal quinine formulation in children with Plasmodium falciparum malaria. Br J Clin Pharmacol 1996;41:389-95.
12. 12. Iliadis A, Brown C, Huggins ML. Apis: a software for model identification, simulation and dosage regimens calculation in clinical and experimental pharmacokinetics. Comp Methods Programs Biomed 1992;38:227-39.
13. 13. Gibaldi M, Perrier D. Pharmacokinetics. 2nd ed. New York: Marcel Dekker; 1982.
14. 14. WHO Working group. Use and interpretation of anthropometric indicators of nutritional status. Bull World Health Organ 1986;64:929-41.
15. 15. Monnet D, Ahouty CP, Malan KA, Houenou AY, Tebi A, Yapo AE. Profil proteique dans les états de malnutrition de l'enfant ivoirien. Bull Soc Pathol Exot 1995;88:50-3.
16. 16. Sachs E, Bernstein LH. Protein markers of nutrition status as related to sex and age. Clin Chem 1986;32:339-41.
17. 1-acid glycoprotein and plasma from patients with malaria. J Pharm Pharmacol 1992;44:806-11.
18. 1-Acid glycoprotein (orosomucoid) and plasma protein binding of quinine in falciparum malaria. Br J Clin Pharmacol 1991;32:311-5.
19. 19. Karbwang J, Davis TME, Looareesuwan S, Molunto P, Bunnag D, White NJ. A comparison of the pharmacokinetic and pharmacodynamic properties of quinine and quinidine in healthy Thai males. Br J Clin Pharmacol 1993;35:265-71.
20. 20. Silamut K, White N, Looareesuwan S, Warrell DA. Binding of quinine to plasma proteins in falciparum malaria. Am J Trop Med Hyg 1985;34:681-6.
21. 21. Winstanley P, Newton C, Watkins W, Mberu E, Ward S, Warn P, et al. Towards optimal regimens of parenteral quinine for young African children with cerebral malaria: the importance of unbound quinine concentration. Trans R Soc Trop Med Hyg 1993;87:201-6.
22. 22. Supanaranond W, Davis TME, Pukrittayakamee S, Silamut K, Karbwang J, Molunto P, et al. Disposition of oral quinine in acute falciparum malaria. Eur J Clin Pharmacol 1991;40:49-52.
23. 1-acid glycoprotein and the binding of quinine in Malawian children. Br J Clin Pharmacol 1991;32:317-21.
24. 24. White NJ, Looaresuwan S, Silamut K. Red cell quinine concentrations in falciparum malaria. Am J Trop Med Hyg 1983;32:456-60.
25. 25. Pussard E, Verdier F. Antimalarial 4-aminoquinolines: mode of action and pharmacokinetics. Fundam Clin Pharmacol 1994;8:1-17.
26. 26. Salako LA, Sowunmi A. Disposition of quinine in plasma, red blood cells and saliva after oral and intravenous administration to healthy adult Africans. Eur J Clin Pharmacol 1992;42:1771-4.
27. 27. Mansor SM, Taylor TE, McGrath CS, Edwards G, Ward SA, Wirima JJ, et al. The safety and kinetics of intramuscular quinine in Malawian children with moderately severe falciparum malaria. Trans R Soc Trop Med Hyg 1990;84:482-7.
28. 28. Sabchareon A, Chongsuphajaisiddhi T, Attanath P. Serum quinine concentrations following the initial dose in children with falciparum malaria. Southeast Asian J Trop Med Public Health 1982;13:556-62.
29. 29. White NJ, Chanthavanich P, Krishna S, Bunch C, Silamut K. Quinine disposition kinetics. Br J Clin Pharmacol 1983;16:399-403.
30. 30. White NJ, Looareesuwan S, Warrell DA, Warrell MJ, Bunnag D, Harinasuta T. Quinine pharmacokinetics and toxicity in cerebral and uncomplicated falciparum malaria. Am J Med 1982;73:564-72.
31. 31. Pukrittayakamee S, Looareesuwan S, Keeratithakul D, Davis TME, Tejalsavadharm P, Nagachinta B, et al. A study of the factors affecting the metabolic clearance of quinine in malaria. Eur J Clin Pharmacol 1997;52:487-93.
32. 32. Trenholme GM, Williams RL, Rieckmann KH, Frischer H, Carson PE. Quinine disposition during malaria and during induced fever. Clin Pharmacol Ther 1976;19:459-67.
33. 33. Anderson KE. Influences of diet and nutrition on clinical pharmacokinetics. Clin Pharmacokinet 1988;14:325-46.
34. 34. White NJ. Controversies in the management of severe falciparum malaria. Baillière's clinical infectious diseases. Malaria 1995;2:309-29.
35. 35. Van Hensbroek MB, Onyiorah E, Jaffar S, Schneider G, Palmer A, Frenkel J, et al. A trial of artemether or quinine in children with cerebral malaria. N Engl J Med 1996;335:69-75.
36. 36. White NJ, Waller D, Kwiatkowski D, Krishna S, Craddock C, Brewster D. Open comparison of intramuscular chloroquine and quinine in children with severe chloroquine sensitive falciparum malaria. Lancet 1989;2:1313-6.